Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$141.41
+2.1%
$123.61
$96.43
$153.84
$40.09B1.261.94 million shs913,004 shs
Avantor, Inc. stock logo
AVTR
Avantor
$13.73
+1.9%
$12.75
$10.82
$26.14
$9.36B0.9810.66 million shs5.79 million shs
Danaher Corporation stock logo
DHR
Danaher
$205.54
-1.5%
$200.40
$171.00
$279.41
$147.08B0.774.24 million shs2.79 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$60.43
+2.1%
$54.23
$46.01
$80.80
$9.40B1.482.14 million shs1.53 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-2.17%+8.08%+7.68%+14.07%-3.70%
Avantor, Inc. stock logo
AVTR
Avantor
-4.51%+7.81%+1.20%-1.14%-46.18%
Danaher Corporation stock logo
DHR
Danaher
-1.42%+5.34%+4.15%+3.83%-22.38%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-4.41%+6.40%+8.79%+12.55%-19.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$141.41
+2.1%
$123.61
$96.43
$153.84
$40.09B1.261.94 million shs913,004 shs
Avantor, Inc. stock logo
AVTR
Avantor
$13.73
+1.9%
$12.75
$10.82
$26.14
$9.36B0.9810.66 million shs5.79 million shs
Danaher Corporation stock logo
DHR
Danaher
$205.54
-1.5%
$200.40
$171.00
$279.41
$147.08B0.774.24 million shs2.79 million shs
Bio-Techne Corp stock logo
TECH
Bio-Techne
$60.43
+2.1%
$54.23
$46.01
$80.80
$9.40B1.482.14 million shs1.53 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-2.17%+8.08%+7.68%+14.07%-3.70%
Avantor, Inc. stock logo
AVTR
Avantor
-4.51%+7.81%+1.20%-1.14%-46.18%
Danaher Corporation stock logo
DHR
Danaher
-1.42%+5.34%+4.15%+3.83%-22.38%
Bio-Techne Corp stock logo
TECH
Bio-Techne
-4.41%+6.40%+8.79%+12.55%-19.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.57
Moderate Buy$147.924.60% Upside
Avantor, Inc. stock logo
AVTR
Avantor
2.47
Hold$15.6514.05% Upside
Danaher Corporation stock logo
DHR
Danaher
2.77
Moderate Buy$244.6019.00% Upside
Bio-Techne Corp stock logo
TECH
Bio-Techne
2.60
Moderate Buy$70.1716.11% Upside

Current Analyst Ratings Breakdown

Latest AVTR, TECH, A, and DHR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Danaher Corporation stock logo
DHR
Danaher
Redburn Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$220.00
10/8/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/8/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralBuy$130.00 ➝ $170.00
10/8/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$165.00
10/8/2025
Danaher Corporation stock logo
DHR
Danaher
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/8/2025
Danaher Corporation stock logo
DHR
Danaher
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyNeutral$245.00 ➝ $220.00
10/8/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/7/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetIn-Line$128.00 ➝ $140.00
10/7/2025
Danaher Corporation stock logo
DHR
Danaher
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$226.00 ➝ $245.00
10/7/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$60.00 ➝ $72.00
10/6/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B6.16$6.24 per share22.66$20.53 per share6.89
Avantor, Inc. stock logo
AVTR
Avantor
$6.78B1.38$1.57 per share8.76$8.75 per share1.57
Danaher Corporation stock logo
DHR
Danaher
$23.88B6.16$10.61 per share19.38$68.60 per share3.00
Bio-Techne Corp stock logo
TECH
Bio-Techne
$1.22B7.71$2.39 per share25.33$12.24 per share4.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.2633.2023.264.6217.97%25.51%12.94%11/24/2025 (Estimated)
Avantor, Inc. stock logo
AVTR
Avantor
$711.50M$0.9913.8611.444.5410.31%11.39%5.44%10/29/2025 (Estimated)
Danaher Corporation stock logo
DHR
Danaher
$3.90B$4.7043.7023.983.0214.21%10.70%6.85%10/21/2025 (Estimated)
Bio-Techne Corp stock logo
TECH
Bio-Techne
$73.40M$0.46131.3030.683.956.02%13.43%10.32%10/29/2025 (Estimated)

Latest AVTR, TECH, A, and DHR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2025Q3 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.23N/AN/AN/A$1.65 billionN/A
10/29/2025Q1 2026
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.42N/AN/AN/AN/AN/A
10/21/2025Q3 2025
Danaher Corporation stock logo
DHR
Danaher
$1.72N/AN/AN/A$6.00 billionN/A
8/27/2025Q3 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.37$1.37N/A$1.18$1.67 billion$1.74 billion
8/6/2025Q4 2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.50$0.53+$0.03-$0.11$315.14 million$316.96 million
8/1/2025Q2 2025
Avantor, Inc. stock logo
AVTR
Avantor
$0.25$0.24-$0.01$0.09$1.67 billion$1.68 billion
7/22/2025Q2 2025
Danaher Corporation stock logo
DHR
Danaher
$1.64$1.80+$0.16$0.77$5.83 billion$5.94 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.70%N/A23.24%9 Years
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Danaher Corporation stock logo
DHR
Danaher
$1.280.62%N/A27.23%2 Years
Bio-Techne Corp stock logo
TECH
Bio-Techne
$0.320.53%N/A69.57%N/A

Latest AVTR, TECH, A, and DHR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/9/2025
Danaher Corporation stock logo
DHR
Danaher
quarterly$0.320.69%9/26/20259/26/202510/31/2025
9/17/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.24800.77%9/30/20259/30/202510/22/2025
8/6/2025
Bio-Techne Corp stock logo
TECH
Bio-Techne
quarterly$0.080.59%8/18/20258/18/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.53
2.25
1.71
Avantor, Inc. stock logo
AVTR
Avantor
0.48
0.98
0.67
Danaher Corporation stock logo
DHR
Danaher
0.32
1.62
1.22
Bio-Techne Corp stock logo
TECH
Bio-Techne
0.18
3.46
2.38

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Danaher Corporation stock logo
DHR
Danaher
79.05%
Bio-Techne Corp stock logo
TECH
Bio-Techne
98.95%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Avantor, Inc. stock logo
AVTR
Avantor
1.20%
Danaher Corporation stock logo
DHR
Danaher
11.20%
Bio-Techne Corp stock logo
TECH
Bio-Techne
1.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900283.50 millionN/AOptionable
Avantor, Inc. stock logo
AVTR
Avantor
13,500681.74 million673.56 millionOptionable
Danaher Corporation stock logo
DHR
Danaher
63,000716.05 million635.85 millionOptionable
Bio-Techne Corp stock logo
TECH
Bio-Techne
3,100155.69 million153.67 millionOptionable

Recent News About These Companies

Zacks Research Upgrades Bio-Techne (NASDAQ:TECH) to "Hold"
5 Analysts Assess Bio-Techne: What You Need To Know
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know
Bio-Techne (NASDAQ:TECH) Trading Up 4.7% - What's Next?
Brokerages Set Bio-Techne Corp (NASDAQ:TECH) Target Price at $70.42

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$141.41 +2.85 (+2.06%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Avantor stock logo

Avantor NYSE:AVTR

$13.72 +0.26 (+1.89%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Danaher stock logo

Danaher NYSE:DHR

$205.54 -3.23 (-1.55%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Bio-Techne stock logo

Bio-Techne NASDAQ:TECH

$60.43 +1.24 (+2.09%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.